Click Here to view the CEVR Fall 2015 Newsletter.
The 2nd Panel on Cost-Effectiveness in Health and Medicine has posted for public comment selected draft chapters for its updated book, Cost-Effectiveness in Health and Medicine.
For information on the project and instructions about reading draft chapters and posting comments, click here.
Pharmacoeconomics in Alzheimer's Disease Conference, November 19-20 in Boston CEVR was pleased to co-host (along with the Karolinska Institutet and the Alzheimer’s Drug Discovery Foundation) the International Pharmacoeconomic Conference on Alzheimer’s Disease (IPECAD). Visit www.ipecad.org for more information.
CEA Registry update: The database now includes a total of 4,339 cost-utility analyses and 11,880 cost-effectiveness ratios.
Growth and change in the CUA literature CEVR researchers published a new paper in Value in Health: “The Changing Face of the Cost-Utility Literature."